Stocks-BBIO-Bridgebio Pharma Inc

BBIO Bridgebio Pharma Inc

28.47 -0.37 (-1.28%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade
Trade

Upcoming Events

22
FEB
REPORTS
Bridgebio Pharma Inc Q4 2023 earnings report is expected to be released before the market opens

Analyst Forecast

Consensus
Moderate Buy
Price Target
50.00

ESG: A New Source of Insight

Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
37
Very Low
Industry 
Avg. 44 
39
Environment
44
Social
24
Governance

People Also Bought